EUCTR2011-005795-42-DE进行中（未招募）不适用
An Open-label, Multicenter Phase 1/2 Study of JNJ-40346527, an FMS Inhibitor, in Subjects with Relapsed or Refractory Hodgkin Lymphoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patients with histopathologically confirmed initial diagnosis of Hodgkin lymphoma and who have disease that has relapsed or is refractory that is progressing or active and requires treatment after at least 1 appropriate therapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 58
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •1. Known brain metastases or leptomeningeal disease.
- •2.Other malignancy within past 5 years.
- •3.Has any condition that, in the opinion of the investigator, would make study participation not be in the best interest (eg, compromise the well-being) of the patient or that could prevent, limit, or confound the protocol-specified assessments.
研究者
相似试验
已完成
不适用
An Open-label, Multicenter, Phase 1b Study of JNJ-63723283, a PD-1 Inhibitor, Administered in Combination with Apalutamide in Subjects with Metastatic Castration- Resistant Prostate CancerNL-OMON50489Janssen-Cilag8
进行中（未招募）
1 期
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell non-Hodgkin Lymphoma (r/r B-NHL)on-Hodgkin Lymphoid MalignanciesCancerISRCTN17666983Janssen-Cilag International NV92
进行中（未招募）
1 期
An Open Label Study of JNJ-68284528, Directed Against BCMA in Subjects with Multiple MyelomaMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2018-004124-10-ESJanssen-Cilag International NV80
进行中（未招募）
1 期
An Open Label Study of JNJ-68284528, Directed Against BCMA in Subjects with Multiple MyelomaMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2018-004124-10-BEJanssen-Cilag International NV171
进行中（未招募）
1 期
An Open Label Study of JNJ-68284528, Directed Against BCMA in Subjects with Multiple MyelomaMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2018-004124-10-DEJanssen-Cilag International NV171